Anticancer Drugs Course
This Anticancer Drugs Course equips oncology professionals with practical skills to master first-line EGFR TKI strategies for EGFR-mutated NSCLC. Participants learn to manage toxicities effectively, navigate resistance challenges, optimise patient outcomes, and communicate treatment plans clearly using evidence-based approaches grounded in current trial data.

4 to 360 hours flexible workload
valid certificate in your country
What will I learn?
Gain a practical overview of first-line systemic treatments for EGFR-mutated NSCLC, covering targeted therapies, chemo-immunotherapy, and chemotherapy. Master drug mechanisms, dosing schedules, toxicity profiles, prevention and management tactics, resistance mechanisms, second-line therapies, monitoring protocols, and patient communication skills for evidence-based decisions.
Elevify advantages
Develop skills
- Select optimal EGFR TKI first-line treatments based on latest clinical trial data.
- Plan resistance assessments including imaging, re-biopsy, and liquid biopsy for therapy guidance.
- Develop second-line plans matching resistance to targeted therapies, chemo, or trials.
- Prevent and manage key toxicities like EGFR TKI rash, diarrhoea, ILD, and cytopenias.
- Deliver clear patient counselling on treatment goals, side effects, and progression strategies.
Suggested summary
Before starting, you can change the chapters and the workload. Choose which chapter to start with. Add or remove chapters. Increase or decrease the course workload.What our students say
FAQs
Who is Elevify? How does it work?
Do the courses have certificates?
Are the courses free?
What is the course workload?
What are the courses like?
How do the courses work?
What is the duration of the courses?
What is the cost or price of the courses?
What is an online course and how does it work?
PDF Course